Aripiprazole: pharmacology, efficacy, safety and tolerability. - Wikidata - wikimedia - TriplyDB

Aripiprazole: pharmacology, efficacy, safety and tolerability.

Aripiprazole: pharmacology, efficacy, safety and tolerability.

http://www.wikidata.org/entity/Q34558285

about

Antipsychotic drug action: targets for drug discovery with neurochemical imaging.The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence.Treatment of psychosis: 30 years of progress.Role of aripiprazole in treating mood disorders.Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment.Aripiprazole augmentation in highly treatment-resistant obsessive-compulsive disorder - experience from a specialty clinic in India.Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole.Aripiprazole in the treatment of refractory mood disorders: a case series.Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.

P2860

Q31032036-71C9E3B9-F747-4D8C-A327-788EF097AC1A Q33707895-8AEAB5CB-E589-4903-9B17-E3AD4E7865AE Q35015469-45C3DD83-E3AD-4F5C-A4D9-256DD56B6D13 Q36687060-7FB7AA0D-BAA0-4657-A7AB-BDE28C66312B Q36688973-A5353DB2-82C2-43AD-819B-C672C548A9E0 Q37947687-9E044AE4-A5EC-4D34-A97B-6A3763073805 Q39389604-C5F08402-24DF-499B-89C3-9517653EF188 Q41528294-C3A29110-EA05-42F1-A841-B8881AC1E88B Q42860058-BEC4D1A3-B970-4035-9309-DFB3F6078F7D Q47920400-973674C4-D407-4382-8692-DA24EFC6132C Q51797175-36441E5F-B302-4C0D-BE63-C786614C0A68

P2860

Aripiprazole: pharmacology, efficacy, safety and tolerability.

http://www.wikidata.org/entity/Q34558285

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@ast

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@en

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@nl

type

label

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@ast

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@en

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@nl

prefLabel

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@ast

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@en

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@nl

P1433

Q34558285-BC58A423-23C4-4E1B-A49C-BC99F011F8B3

P1476

Q34558285-C929FEE0-A9B8-45A4-8B72-92ECC408D606

P2093

Q34558285-0BCA7B79-FDA7-4D6E-A36C-2EB630A32503

Q34558285-CDFF5212-FDB9-434E-8D17-037EF31C3D23

P2860

Q34558285-199B84CE-91FD-4E14-B9CC-AEBE838824D9

Q34558285-1A4EB810-A689-4AE5-A34D-6F858AE4798A

Q34558285-26452386-AE54-4344-A8BD-16DB76115A23

Q34558285-2D0DAC9D-616E-4819-A446-3649C2FE9A10

Q34558285-3726EBAF-2423-4E21-898D-9FE12577C0E5

Q34558285-40657171-BF05-4FF4-A107-67A6586210E1

Q34558285-6BCC7037-ACEF-4283-879B-B78E4298814B

Q34558285-6E6F5E53-5332-4BC3-BA2D-BE0B5850117F

Q34558285-729D1847-C0B1-4156-A338-5445FBE5BB4A

Q34558285-7627496E-E104-4099-A749-009D9F7F028D

P304

Q34558285-4045D050-84BA-422C-9B2C-9365EBDAF128

P31

Q34558285-EC723C27-CCF4-4031-BDCC-66A7333F20DC

P356

Q34558285-B3C45D55-267C-46A6-A89D-6FCFF61DAD28

P433

Q34558285-A7129732-70C1-47AB-85DF-53DFFE5B4351

P478

Q34558285-0BC8CE01-6AB1-446A-9A8E-C4DED934A3AE

P577

Q34558285-915216DE-D891-448F-8C1A-6BD8DF9C76EA

P698

Q34558285-A008ED64-A75E-4125-ADA4-13CC2ED7F5B8

P921

Q34558285-A048157B-2BE8-435A-9CD8-D2C605381D55

P356

14737175.5.3.297

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Aripiprazole: pharmacology, efficacy, safety and tolerability.

@en

P2093

Joseph P McEvoy

http://www.w3.org/2001/XMLSchema#string

Warren A Kinghorn

http://www.w3.org/2001/XMLSchema#string

P2860

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

Consensus development conference on antipsychotic drugs and obesity and diabetes.

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.

Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.

Mechanism of new antipsychotic medications: occupancy is not just antagonism.

Clinical utilization of atypical antipsychotics in pregnancy and lactation.

Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders.

P304

297-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.5.3.297

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15938662

http://www.w3.org/2001/XMLSchema#string

P921